Steven McAllister

2014

In 2014, Steven McAllister earned a total compensation of $707.1K as Chief Financial Officer at InVivo Therapeutics Holdings, a 70,609% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$106,375
Option Awards$305,300
Salary$262,692
Stock Awards$19,875
Other$12,850
Total$707,092

McAllister received $305.3K in option awards, accounting for 43% of the total pay in 2014.

McAllister also received $106.4K in non-equity incentive plan, $262.7K in salary, $19.9K in stock awards and $12.9K in other compensation.

Rankings

In 2014, Steven McAllister's compensation ranked 9,004th out of 13,032 executives tracked by ExecPay. In other words, McAllister earned more than 30.9% of executives.

ClassificationRankingPercentile
All
9,004
out of 13,032
31st
Division
Manufacturing
3,363
out of 4,966
32nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
456
out of 736
38th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
257
out of 446
42nd
Industry
Surgical and Medical Instruments and Apparatus
154
out of 275
44th
Source: SEC filing on April 25, 2017.

McAllister's colleagues

We found four more compensation records of executives who worked with Steven McAllister at InVivo Therapeutics Holdings in 2014.

2014

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2014

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2014

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2014

Michael Astrue

InVivo Therapeutics Holdings

Chief Executive Officer

You may also like